CYP2F1
Basic information
Region (hg38): 19:41114432-41128381
Previous symbols: [ "CYP2F" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CYP2F1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 51 | 58 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 51 | 2 | 7 |
Variants in CYP2F1
This is a list of pathogenic ClinVar variants found in the CYP2F1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-41116195-A-G | not specified | Uncertain significance (Dec 04, 2024) | ||
19-41116201-A-T | not specified | Uncertain significance (Dec 12, 2023) | ||
19-41116202-G-A | not specified | Uncertain significance (Jul 09, 2021) | ||
19-41116202-G-GC | not specified | Benign (Mar 28, 2016) | ||
19-41116210-A-G | not specified | Uncertain significance (May 13, 2024) | ||
19-41116229-C-T | not specified | Uncertain significance (Jul 31, 2024) | ||
19-41116234-G-A | not specified | Uncertain significance (Sep 27, 2021) | ||
19-41116336-G-C | not specified | Uncertain significance (Feb 14, 2024) | ||
19-41116341-G-A | not specified | Uncertain significance (Dec 24, 2024) | ||
19-41116351-C-T | not specified | Uncertain significance (Apr 05, 2023) | ||
19-41116464-G-A | not specified | Likely benign (Apr 19, 2023) | ||
19-41116521-G-A | not specified | Uncertain significance (Feb 16, 2023) | ||
19-41116576-G-C | Benign (Mar 07, 2018) | |||
19-41116587-C-T | not specified | Uncertain significance (Apr 06, 2024) | ||
19-41120339-C-G | Benign (Feb 09, 2018) | |||
19-41120371-G-A | not specified | Uncertain significance (Oct 04, 2022) | ||
19-41120389-A-G | not specified | Likely benign (Sep 03, 2024) | ||
19-41120389-A-T | not specified | Uncertain significance (Jan 09, 2025) | ||
19-41120394-T-G | not specified | Uncertain significance (Nov 17, 2023) | ||
19-41120398-T-A | not specified | Uncertain significance (Nov 06, 2023) | ||
19-41120421-A-T | not specified | Uncertain significance (Jul 12, 2023) | ||
19-41120437-T-C | not specified | Uncertain significance (Oct 09, 2024) | ||
19-41120446-G-A | not specified | Uncertain significance (Jan 04, 2024) | ||
19-41120485-G-A | not specified | Uncertain significance (Aug 20, 2024) | ||
19-41121476-C-A | not specified | Uncertain significance (Mar 20, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CYP2F1 | protein_coding | protein_coding | ENST00000331105 | 9 | 13935 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.41e-9 | 0.322 | 79498 | 6001 | 40249 | 125748 | 0.205 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.00200 | 311 | 311 | 1.00 | 0.0000196 | 3188 |
Missense in Polyphen | 95 | 100.87 | 0.94178 | 1029 | ||
Synonymous | 0.785 | 124 | 136 | 0.914 | 0.00000893 | 1006 |
Loss of Function | 0.771 | 15 | 18.6 | 0.807 | 9.39e-7 | 207 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.537 | 0.536 |
Ashkenazi Jewish | 0.166 | 0.163 |
East Asian | 0.249 | 0.249 |
Finnish | 0.244 | 0.243 |
European (Non-Finnish) | 0.189 | 0.188 |
Middle Eastern | 0.249 | 0.249 |
South Asian | 0.228 | 0.226 |
Other | 0.192 | 0.188 |
dbNSFP
Source:
- Function
- FUNCTION: May be involved in the metabolism of various pneumotoxicants including naphthalene. Is able to dealkylate ethoxycoumarin, propoxycoumarin, and pentoxyresorufin but possesses no activity toward ethoxyresorufin and only trace dearylation activity toward benzyloxyresorufin. Bioactivates 3- methylindole (3MI) by dehydrogenation to the putative electrophile 3-methylene-indolenine. {ECO:0000269|PubMed:1974816}.;
- Pathway
- Metabolism of xenobiotics by cytochrome P450 - Homo sapiens (human);Oxidation by Cytochrome P450;Tryptophan metabolism;Metapathway biotransformation Phase I and II;Phase I - Functionalization of compounds;Xenobiotics;Tyrosine metabolism;Fatty acids;Androgen and estrogen biosynthesis and metabolism;Cytochrome P450 - arranged by substrate type;Leukotriene metabolism;Biological oxidations;Metabolism;Linoleate metabolism;C21-steroid hormone biosynthesis and metabolism;Xenobiotics metabolism;Tryptophan degradation;CYP2E1 reactions;Arachidonic acid metabolism
(Consensus)
Intolerance Scores
- loftool
- 0.824
- rvis_EVS
- 1
- rvis_percentile_EVS
- 90.77
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.208
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.317
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | High | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Gene ontology
- Biological process
- organic acid metabolic process;xenobiotic metabolic process;response to toxic substance;naphthalene metabolic process;trichloroethylene metabolic process;epoxygenase P450 pathway;exogenous drug catabolic process;oxidation-reduction process
- Cellular component
- cytoplasm;endoplasmic reticulum membrane;organelle membrane;intracellular membrane-bounded organelle
- Molecular function
- monooxygenase activity;iron ion binding;arachidonic acid epoxygenase activity;steroid hydroxylase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;oxygen binding;heme binding;aromatase activity